Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
| dc.contributor.author | Dejnirattisai W. | |
| dc.contributor.other | Mahidol University | |
| dc.date.accessioned | 2023-06-20T05:35:48Z | |
| dc.date.available | 2023-06-20T05:35:48Z | |
| dc.date.issued | 2022-01-15 | |
| dc.identifier.citation | The Lancet Vol.399 No.10321 (2022) , 234-236 | |
| dc.identifier.doi | 10.1016/S0140-6736(21)02844-0 | |
| dc.identifier.eissn | 1474547X | |
| dc.identifier.issn | 01406736 | |
| dc.identifier.pmid | 34942101 | |
| dc.identifier.scopus | 2-s2.0-85122668243 | |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/87388 | |
| dc.rights.holder | SCOPUS | |
| dc.subject | Medicine | |
| dc.title | Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum | |
| dc.type | Letter | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122668243&origin=inward | |
| oaire.citation.endPage | 236 | |
| oaire.citation.issue | 10321 | |
| oaire.citation.startPage | 234 | |
| oaire.citation.title | The Lancet | |
| oaire.citation.volume | 399 | |
| oairecerif.author.affiliation | Siriraj Hospital | |
| oairecerif.author.affiliation | Oxford University Hospitals NHS Foundation Trust | |
| oairecerif.author.affiliation | Diamond Light Source | |
| oairecerif.author.affiliation | The Wellcome Centre for Human Genetics | |
| oairecerif.author.affiliation | University of Nottingham Medical School | |
| oairecerif.author.affiliation | University of Oxford | |
| oairecerif.author.affiliation | Nuffield Department of Medicine | |
| oairecerif.author.affiliation | University of Oxford Medical Sciences Division | |
| oairecerif.author.affiliation | Oxford House |